We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.92%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$43.9B
AUM Growth
+$2.87B
(+7%)
Cap. Flow
-$890M
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
13.25%
Holding
2,343
New
170
Increased
997
Reduced
1,015
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$111M |
| 2 |
Verizon
VZ
|
+$103M |
| 3 |
AT&T
T
|
+$103M |
| 4 |
Kroger
KR
|
+$97.1M |
| 5 |
3M
MMM
|
+$92.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$138M |
| 2 |
Tesla
TSLA
|
+$110M |
| 3 |
JPMorgan Chase
JPM
|
+$103M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$89.4M |
| 5 |
Apple
AAPL
|
+$85.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 16.25% |
| 3 | Financials | 11.85% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRY
876
DELISTED
Berry Corp
BRY
| $5.12M | 0.01% |
639,429
+350,080
| +121% | +$3M |
|
877
Kelly Services Class A
KELYA
$536M
| $5.11M | 0.01% |
302,524
+78,098
| +35% | +$1.25M |
|
878
Bloomin' Brands
BLMN
$952M
| $5.11M | 0.01% |
254,067
+132,317
| +109% | +$2.87M |
|
879
BioMarin Pharmaceuticals
BMRN
$13.5B
| $5.1M | 0.01% |
50,195
+21,108
| +73% | +$1.98M |
|
|
AVNS
880
DELISTED
Avanos Medical
AVNS
| $5.1M | 0.01% |
188,717
+49,448
| +36% | +$1.21M |
|
881
Alkermes
ALKS
$8.26B
| $5.09M | 0.01% |
194,939
+13,191
| +7% | +$316K |
|
882
Globe Life
GL
$14.1B
| $5.09M | 0.01% |
42,196
-24,303
| -37% | -$2.78M |
|
883
MYR Group
MYRG
$5.14B
| $5.08M | 0.01% |
55,135
-3,762
| -6% | -$341K |
|
884
Edison International
EIX
$26.9B
| $5.06M | 0.01% |
79,591
+12,710
| +19% | +$780K |
|
|
RPT
885
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $5.06M | 0.01% |
503,699
+1,421
| +0.3% | +$14K |
|
886
Uber
UBER
$160B
| $5.05M | 0.01% |
206,151
-7,787
| -4% | -$213K |
|
|
VTLE
887
DELISTED
Vital Energy
VTLE
| $5.05M | 0.01% |
98,264
+48,713
| +98% | +$3.01M |
|
888
G-III Apparel Group
GIII
$1.44B
| $5.05M | 0.01% |
368,406
+172,602
| +88% | +$2.9M |
|
889
Encompass Health
EHC
$12.4B
| $5.02M | 0.01% |
84,378
-11,499
| -12% | -$625K |
|
890
Madison Square Garden
MSGS
$9.47B
| $5.02M | 0.01% |
27,771
+12,080
| +77% | +$1.89M |
|
891
Flowserve
FLS
$10.3B
| $5.01M | 0.01% |
164,389
-32,970
| -17% | -$962K |
|
892
TTM Technologies
TTMI
$13.8B
| $4.99M | 0.01% |
330,826
+84,695
| +34% | +$1.26M |
|
893
Alto Ingredients
ALTO
$323M
| $4.99M | 0.01% |
1,731,056
+1,209,314
| +232% | +$4.3M |
|
894
OFG Bancorp
OFG
$2.22B
| $4.97M | 0.01% |
180,204
+31,639
| +21% | +$869K |
|
|
SEE
895
DELISTED
Sealed Air
SEE
| $4.97M | 0.01% |
100,044
-113,065
| -53% | -$5.52M |
|
896
MaxLinear
MXL
$6.26B
| $4.96M | 0.01% |
146,087
+8,115
| +6% | +$275K |
|
897
Peabody Energy
BTU
$2.98B
| $4.95M | 0.01% |
187,195
+21,062
| +13% | +$579K |
|
898
Freeport-McMoran
FCX
$96.4B
| $4.94M | 0.01% |
130,378
-218,878
| -63% | -$7.65M |
|
899
Eagle Bancorp
EGBN
$865M
| $4.92M | 0.01% |
111,654
+24,544
| +28% | +$1.11M |
|
900
M/I Homes
MHO
$3.85B
| $4.91M | 0.01% |
106,414
+19,142
| +22% | +$822K |
|
Similar funds
VGA
AQR Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, AQR Capital Management held 2,343 positions worth $43.9B, up 7% from $41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2022 filing shows 170 new, 997 increased, 1,015 reduced and 150 closed positions. Its largest new stake was Generac Holdings: 310,080 shares worth $30.5M. The largest sale was Gilead Sciences, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q4 2022 buy was Generac Holdings: 310,080 shares worth $30.5M.
- AQR Capital Management added most to Humana in Q4 2022, an estimated $111M increase.
- AQR Capital Management's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $138M.
- AQR Capital Management fully exited Abiomed Inc in Q4 2022, selling an estimated $22.4M.
- AQR Capital Management's ten largest holdings make up 13% of its $43.9B portfolio in Q4 2022.
- AQR Capital Management opened 170 new positions and closed 150 in Q4 2022.
- AQR Capital Management's portfolio value rose 7% quarter-over-quarter to $43.9B.
Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.